LTGO
Latigo Biotherapeutics Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$15.54
−1.83%2
Insider buys (3m)
0
Insider sells (3m)
$5.0M
Net value (3m)
-10.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 10, 2026 | Foresite Capital Management V, LLC · 10 percent owner | Purchase | 140,000 | $18 |
| Aug 10, 2026 | SMITH TODD N · director | A-Award | 105,542 | $18 |
| Aug 10, 2026 | Tananbaum James B. · director, 10 percent owner: | Purchase | 140,000 | $18 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 10, 2026